Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip B Mitchell

Showing results (211-220 of 315) with videos related to

Pageof 32
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 7, 2017
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statementSeetal Dodd, Philip B Mitchell, Michael Bauer, et al.
The Australian and New Zealand Journal of Psychiatry|September 6, 2011
A consensus statement for safety monitoring guidelines of treatments for major depressive disorderSeetal Dodd, Gin S Malhi, John Tiller, et al.
Journal of Affective Disorders|September 10, 2025
Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatmentClara Massaneda-Tuneu, Donel Martin, Nicholas Glozier, et al.
Bipolar Disorders|March 4, 2022
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorderMelvin G McInnis, Ole A Andreassen, Ana C Andreazza, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
Translational Psychiatry|August 3, 2022
Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorderSonia Hesam-Shariati, Bronwyn J Overs, Gloria Roberts, et al.
Bipolar Disorders|July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersMauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Schizophrenia Research|October 30, 2012
Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibilityMing Li, Yi Wang, Xue-bin Zheng, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
The Australian and New Zealand Journal of Psychiatry|December 20, 2014
Why academic psychiatry is endangeredScott Henderson, Richard J Porter, Darryl Basset, et al.
Pageof 32

Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 7, 2017
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statementSeetal Dodd, Philip B Mitchell, Michael Bauer, et al.
The Australian and New Zealand Journal of Psychiatry|September 6, 2011
A consensus statement for safety monitoring guidelines of treatments for major depressive disorderSeetal Dodd, Gin S Malhi, John Tiller, et al.
Journal of Affective Disorders|September 10, 2025
Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatmentClara Massaneda-Tuneu, Donel Martin, Nicholas Glozier, et al.
Bipolar Disorders|March 4, 2022
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorderMelvin G McInnis, Ole A Andreassen, Ana C Andreazza, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
Translational Psychiatry|August 3, 2022
Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorderSonia Hesam-Shariati, Bronwyn J Overs, Gloria Roberts, et al.
Bipolar Disorders|July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersMauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Schizophrenia Research|October 30, 2012
Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibilityMing Li, Yi Wang, Xue-bin Zheng, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
The Australian and New Zealand Journal of Psychiatry|December 20, 2014
Why academic psychiatry is endangeredScott Henderson, Richard J Porter, Darryl Basset, et al.
Pageof 32